The Department of Health is committed to ensuring that all essential medicines are available, at the appropriate level of care, to all patients in need. From time to time there are interruptions in the availability of medicines at the facility level.
The medicine supply chain is long and complex, with interruptions at any point in the supply chain affecting medicine availability at the facility. These interruptions may relate to, inter alia, the shortage of the active ingredients, regulatory issues affecting formulation, logistical challenges, inadequate volumes produced relative to the ordered quantity and inadequate quantities being ordered.
A number of interventions have been implemented to address potential risks in the supply chain. However, these interventions may not always avert a shortage or stock out. The list below identifies those medicines where the interventions implemented may not have been able to avert a shortage and reflects those medicines which manufacturers have been unable to supply.
The list is updated on a monthly basis by the Affordable Medicines Directorate Improved Medicine Availability Team (IMAT). If you are aware of items that are in short supply but which are not on the list, please notify the Department using the following e-mail address: firstname.lastname@example.org.
API – Active Pharmaceutical Ingredient
Discontinuation – The medicine will no longer be manufactured
Forecast – The prediction/estimation of the volumes
GMP – Good Manufacturing Practices
Regulatory – Concerns the control around the production, distribution, and use of the medicine
Short term supply constraint
Draft_HTA Methods Guide_v1.2_14Jun21
|Annexure 1 - HTA Methods Guide_Consultation response form_July 2021||DOWNLOAD|
|EDP_HTA Methods Guide_Request for Comment_July 2021||DOWNLOAD|
|1_Health Technology Motivation_template_170621_DRAFT||DOWNLOAD|
|2_Health Technology Scope_template_170621_DRAFT||DOWNLOAD|
|3_Technical Review Report_template_170621_DRAFT||DOWNLOAD|
|5_RR of Econ Evaluations_template_170621_DRAFT||DOWNLOAD|
|7b_Budget Impact Analysis_template_170621_DRAFT||DOWNLOAD|
|7a_Budget Impact Analysis_template_170621_DRAFT||DOWNLOAD|
|Hot list - February 2020||DOWNLOAD|